Literature DB >> 33866381

The exploration of quantitative intra-tumoral metabolic heterogeneity in dual-time 18F-FDG PET/CT of pancreatic cancer.

Guorong Jia1, Jian Zhang2, Rou Li1,3, Jianhua Yan4, Changjing Zuo5.   

Abstract

PURPOSE: We aimed to analyze the change of quantitative intra-tumoral metabolic heterogeneity consisting of texture features and conventional metabolic parameters of pancreatic cancer (PC) in dual-time 2-deoxy-2(18F) fluoro-D-glucose (18F-FDG) positron emission tomography-computed tomography (PET/CT).
METHODS: A retrospective analysis was conducted considering the texture features and conventional metabolic parameters in dual-time 18F-FDG PET/CT scans of PC patients. Features were extracted based on spatial distribution of 18F-FDG uptake in image. Firstly, the texture features and the conventional metabolic parameters of the delayed scan were both compared with that of the early scan. Statistically different data was defined among them. Secondly, the study evaluated the correlations between retention index (RI) of the texture features and the conventional metabolic parameters. Finally, the variation of texture features in dual-time PET/CT of resectable PC patients and unresectable PC patients was calculated separately.
RESULTS: In total, 183 PC patients were analyzed retrospectively in this research. The conventional metabolic parameters were all statistically different between the early and delayed scans except for metabolic tumor volume (MTV). In the radiomics, there were 59 textural features. Nineteen of 59 texture features were statistically different between the early and delayed scans. Features that were more than 10% different during two scans were observed in a substantial percentage of patients. Weak correlations were only found between MTV, TLG (Total lesion glycolysis), SUVpeak and the RI of some texture features in early or delayed scans. There were obviously fewer features with significant difference in resectable PC group than in unresectable PC group. Most features showing the difference in unresectable group while no significant difference in resectable group.
CONCLUSIONS: This study investigated the change and inner correlations of quantitative tumoral metabolic heterogeneity in the dual-time 18F-FDG-PET/CT scan of PC patients. Some features displayed the difference between dual-time scans. Conventional metabolic parameters were weakly related to the change of texture feature. The change of texture feature in resectable PC group was different from that in unresectable PC group. This result is potential to provide more information for the image evaluation of PC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Heterogeneity; Pancreatic neoplasms; Positron emission tomography-computed tomography; Texture analysis

Mesh:

Substances:

Year:  2021        PMID: 33866381     DOI: 10.1007/s00261-021-03068-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  23 in total

1.  Helical CT with CT angiography in assessing periampullary neoplasms: identification of vascular invasion.

Authors:  Luigi Lepanto; Yervant Arzoumanian; David Gianfelice; Pierre Perreault; Michel Dagenais; Réal Lapointe; Richard Létourneau; André Roy
Journal:  Radiology       Date:  2002-02       Impact factor: 11.105

Review 2.  Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).

Authors:  Katherine Cameron; Sivan Golan; William Simpson; Steven Peti; Sasan Roayaie; Daniel Labow; Lale Kostakoglu
Journal:  Abdom Imaging       Date:  2011-08

Review 3.  The role of positron emission tomography in the management of pancreatic cancer.

Authors:  Farrokh Pakzad; Ashley M Groves; Peter J Ell
Journal:  Semin Nucl Med       Date:  2006-07       Impact factor: 4.446

Review 4.  Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials.

Authors:  Zhiyi Zhang; Jie Song; Cao Xie; Jun Pan; Weiyue Lu; Min Liu
Journal:  AAPS J       Date:  2021-02-12       Impact factor: 4.009

5.  Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hiroyuki Morisaka; Hironobu Sou; Ali Muhi; Kazufumi Kimura; Katsuhiro Sano; Tsutomu Araki
Journal:  Radiology       Date:  2011-06-21       Impact factor: 11.105

6.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

7.  Modalities for evaluating chemotherapeutic efficacy and survival time in patients with advanced pancreatic cancer: comparison between FDG-PET, CT, and serum tumor markers.

Authors:  Masaki Kuwatani; Hiroshi Kawakami; Kazunori Eto; Shin Haba; Tohru Shiga; Nagara Tamaki; Masahiro Asaka
Journal:  Intern Med       Date:  2009-06-01       Impact factor: 1.271

8.  Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer.

Authors:  Timothy M Pawlik; Daniel Laheru; Ralph H Hruban; Joann Coleman; Christopher L Wolfgang; Kurt Campbell; Syed Ali; Elliot K Fishman; Richard D Schulick; Joseph M Herman
Journal:  Ann Surg Oncol       Date:  2008-05-07       Impact factor: 5.344

9.  Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations.

Authors:  Elena Manak; Susanne Merkel; Peter Klein; Thomas Papadopoulos; Werner A Bautz; Ulrich Baum
Journal:  Abdom Imaging       Date:  2009 Jan-Feb

10.  Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.

Authors:  Hye Jin Choi; Jeong Won Lee; Beodeul Kang; Si Young Song; Jong Doo Lee; Jae-Hoon Lee
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.